BCAB
BioAtlaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The bullish path is that the Context payment stream closes the near-term runway gap and the strategic-options process converts one or more assets into a licensing or sale transaction, preserving some equity value despite the small cash balance [#10-Q-2026-05-15] [#10-K-2026-03-31].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Management disclosed substantial doubt about its ability to continue as a going concern, with approximately $2.0 million of cash and cash equivalents at March 31, 2026 and explicit language that current cash does not fund twelve months [#10-Q-2026-05-15].
Momentum
88
Value
59
Sentiment
55
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.00 · Bull $7.50 · Bear $1.25
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $4.00
Why
Momentum88 · Δ7d -
Value59 · Δ7d +0.0
Sentiment55 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
88
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
59
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
55
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 87.9 / Value 58.8 / Sentiment 54.8
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$5.85M
Beta
1.11
Shares Out
59.04M
P/E (TTM) · Derived
-0.1
P/S (TTM)
4.22
P/FCF (TTM) · Derived
-0.10
Rev YoY
-100.0%
EPS YoY
-22.6%
Gross Margin
-
Op Margin
-579.8%
Net Debt
-$49.05M
Current Ratio
0.54
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology